[EN] COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS
申请人:FOGHORN THERAPEUTICS INC
公开号:WO2020160198A1
公开(公告)日:2020-08-06
The present invention relates to compositions and methods for the treatment of BAF-related disorders, such as cancers and viral infections.
本发明涉及用于治疗与BAF相关的疾病,如癌症和病毒感染的组合物和方法。
PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY
申请人:Agios Pharmaceuticals, Inc.
公开号:EP2704721B1
公开(公告)日:2018-04-11
[EN] TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES TÉTRACYCLIQUES UTILES EN TANT QU'INHIBITEURS DE L'INTÉGRASE DU VIH
申请人:MERCK SHARP & DOHME
公开号:WO2018102485A1
公开(公告)日:2018-06-07
The present invention relates to Tetracyclic Heterocycle Compounds of Formula (I): (I) and pharmaceutically acceptable salts or prodrug thereof, wherein A, X, R1, R2, R3 and R7 are as defined herein. The present invention also relates to compositions comprising at least one Tetracyclic Heterocycle Compound, and methods of using the Tetracyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.